1. Home
  2. PMCB vs PCLA Comparison

PMCB vs PCLA Comparison

Compare PMCB & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.74

Market Cap

8.3M

Sector

Health Care

ML Signal

HOLD

Logo PicoCELA Inc. American Depositary Shares

PCLA

PicoCELA Inc. American Depositary Shares

HOLD

Current Price

$2.32

Market Cap

9.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMCB
PCLA
Founded
1996
2008
Country
United States
Japan
Employees
N/A
55
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Building Products
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.3M
9.7M
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
PMCB
PCLA
Price
$0.74
$2.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
158.3K
4.6K
Earning Date
03-17-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
277.22
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$0.12
52 Week High
$1.51
$8.00

Technical Indicators

Market Signals
Indicator
PMCB
PCLA
Relative Strength Index (RSI) 54.65 44.56
Support Level $0.65 $1.94
Resistance Level $0.77 $2.59
Average True Range (ATR) 0.06 0.30
MACD 0.01 0.05
Stochastic Oscillator 70.58 55.07

Price Performance

Historical Comparison
PMCB
PCLA

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

Share on Social Networks: